Inventor · disambiguated record

Jacob Jennings Orme

Also filed as: ORME JACOB · ORME JACOB J · ORME JACOB JENNINGS

2 granted patents·7 pending applications·4 citations·filing 2010–2022

49Inventor score

Technology areasA61K A61P C07K C12N G01N

Files withIMPERIUM BIOTECHNOLOGIES INC4 MAYO FOUND MEDICAL EDUCATION & RES3 LIPIQUESTER LLC1 ORME JACOB1

Top patents by PatentIndex Score

9 records

0164US8383405B2Methods of using ideotypically modulated pharmacoeffectors for selective cell treatmentIMPERIUM BIOTECHNOLOGIES INC·Filed 2010·Granted Feb 26, 2013·2 cites·14 claims
0259US8518409B2System for selective cell treatment using ideotypically modulated pharmacoeffectorsORME JACOB·Filed 2011·Granted Aug 27, 2013·2 cites·15 claims
0353US2024285644A1Assessing and treating prostate cancerMAYO FOUND MEDICAL EDUCATION & RES·Filed 2022·Application pending·0 cites
0449US2023310499A1Plasma exchange removal of spd-l1MAYO FOUND MEDICAL EDUCATION & RES·Filed 2021·Application pending·0 cites
0541US2021361767A1Rescuing cancer patients from resistance to treatment with inhibitors of pd-1/pd-l1 interactionsMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Application pending·0 cites
0639US2014195216A1Computational design of ideotypically modulated pharmacoeffectors for selective cell treatmentIMPERIUM BIOTECHNOLOGIES INC·Filed 2013·Application pending·0 cites
0735US2014057351A1Ideotypically modulated pharmacoeffectors for selective cell treatmentIMPERIUM BIOTECHNOLOGIES INC·Filed 2013·Application pending·0 cites
0833US2019110999A1Prevention of lipid absorption using artificial lipid sequestration devicesLIPIQUESTER LLC·Filed 2017·Application pending·0 cites
0922US2015290284A1Ideotypically modulated pharmacoeffectors for selective cell treatmentIMPERIUM BIOTECHNOLOGIES INC·Filed 2015·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Jacob Jennings Orme files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →